Has Reed Cope, MD received payments from drug or device companies?

Yes. Drug and device makers reported $33,556 in general payments to Reed Cope, MD across 552 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Reed Cope, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Reed Cope, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Reed Cope, MD

Radiation Oncology · Columbia, MONPI 1801214267

Payments from drug & device makers

$33,556in general payments, 2019–2025

Across 552 payments — averaging $60.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Sumitomo Pharma America, Inc.$22K
Novocure Inc.$2K
Merck$1K
Johnson & Johnson$949
Novartis$879
AstraZeneca$649
plus $6K from 54 others

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Sumitomo Pharma America, Inc.	17	$21,633
Novocure Inc.	22	$1,883
Merck	56	$1,096
Johnson & Johnson(2 entities)	52	$949
Novartis	53	$879
AstraZeneca	38	$649
Seagen Inc.	26	$532
AbbVie	21	$443
Pfizer	24	$418
GT Medical Technologies, Inc	3	$364
Eisai Inc.	16	$343
Incyte Corporation	19	$336
Lilly USA, LLC	13	$319
Sanofi	18	$296
Regeneron Healthcare Solutions, Inc.	13	$276
Genentech USA, Inc.	15	$258
Exelixis Inc.	10	$239
Amgen	12	$213
Daiichi Sankyo Inc.	7	$172
Bayer	7	$133
Teleflex LLC	1	$129
Legend Biotech USA Inc.	7	$122
Boehringer Ingelheim	6	$116
Taiho Oncology, Inc.	6	$98
Pharmacyclics LLC, An Abbvie Company	4	$89
GSK	4	$87
Stemline Therapeutics Inc.	4	$80
Sobi, Inc	4	$79
Genmab U.S., Inc.	4	$78
Rigel Pharmaceuticals, Inc.	5	$75
Tersera Therapeutics LLC	3	$71
Beone Medicines USA, Inc.	3	$70
Gilead	4	$69
Morphosys, US Inc.	4	$65
Kyowa Kirin, Inc.	4	$60
Takeda Pharmaceuticals U.S.A., Inc.	3	$52
Karyopharm Therapeutics Inc.	3	$48
Clovis Oncology, Inc.	4	$47
Puma Biotechnology, Inc.	2	$44
Bristol Myers Squibb	3	$43
Adaptive Biotechnologies Corporation	3	$42
EMD Serono, Inc.	2	$42
Blueprint Medicines Corporation	3	$42
Servier Pharmaceuticals LLC	2	$39
Jazz Pharmaceuticals Inc.	2	$38
Caris MPI, Inc.	1	$35
Zap Surgical Systems, Inc.	1	$35
AVEO Pharmaceuticals, Inc.	2	$34
Blue Earth Diagnostics	2	$28
Lexicon Pharmaceuticals, Inc.	1	$26
Springworks Therapeutics, Inc.	1	$26
ADC Therapeutics America, Inc.	1	$24
Pharmacosmos Therapeutics Inc.	1	$21
Dendreon Pharmaceuticals LLC	1	$20
Fresenius Kabi USA, LLC	1	$20
Ambu Inc.	1	$20
Epizyme, Inc.	1	$19
Agios Pharmaceuticals, Inc.	1	$17
AMAG Pharmaceuticals, Inc.	1	$17
Tolmar Pharmaceuticals, Inc.	1	$16

How this compares

$33,556 in reported general payments places this provider in the 80th percentile of 123 radiation oncology providers in Missouri.

See all radiation oncology providers in Missouri →

Medicare billing

Part B allowed, 2024

$606,617

Medicare patients

534

Services billed

3,635

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other radiation oncology in Columbia

Gregory BiedermannColumbia$273K
Bo LuColumbia$48K
Mark BryerColumbia$16K
Harold JohnsonColumbia$9K
Andrew LeikerColumbia$7K
Sana KaramSaint Louis$2.7M
Hiram GaySaint Louis$2M
Clifford RobinsonSaint Louis$1.5M
Lauren HenkeSaint Louis$1.2M
Pamela SamsonSaint Louis$752K

See the full list for Missouri →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →